ZNF384 is highly expressed in CRC and it can affect the metastatic and proliferative capacity of CRC cells through upregulation of hypoxia‐inducible factor 1 alpha (HIF1a) and matrix metalloproteinase 2 (MMP2) [23]. The gene discussed is MMP2; the disease is colorectal carcinoma.